Deals

The pharmacy retailing giant won't be involved in the first reverse merger on the ASX. But it would be the biggest by far.

The retail giant's patient, long-term approach and 100-year vision will be tested when it lands on the ASX via an $8.8 billion reverse merger with Sigma Pharmaceuticals.

Retail media spending in Australia is surging into the billions. That critical mass is diverting potential ad revenue away from incumbent media businesses.

Talk of a possible $80 billion Woodside-Santos merger follows a wave of consolidation in global oil and gas as companies band together for survival.

Soul Patts' takeover bid probably won't succeed, at least under the current proposal, but Perpetual is also unlikely to continue in its current form.

The future of the 137-year-old investment company is uncertain as bidders sense an opportunity to swoop while the chips are down.

The competition regulator and the powerful Pharmacy Guild were both unaware of the two group's plans to merge before the deal leaked yesterday.

If you thought Origin, EIG and Brookfield have been dancing for a while, they're a long way off some of the longest takeover tangos over the last 10 years.

One of Canada’s mining giants is cashed up and being linked with beleaguered ASX nickel and copper play Chalice Mining.

The Canadian investment giant might be tempted to disappear off the local energy scene altogether after seemingly failing in its second big attempt to pull off a landmark climate deal in Australia, this time with Origin.